208 related articles for article (PubMed ID: 10339548)
1. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.
Oberfield JL; Collins JL; Holmes CP; Goreham DM; Cooper JP; Cobb JE; Lenhard JM; Hull-Ryde EA; Mohr CP; Blanchard SG; Parks DJ; Moore LB; Lehmann JM; Plunket K; Miller AB; Milburn MV; Kliewer SA; Willson TM
Proc Natl Acad Sci U S A; 1999 May; 96(11):6102-6. PubMed ID: 10339548
[TBL] [Abstract][Full Text] [Related]
2. A selective peroxisome proliferator-activated receptor-gamma (PPARgamma) modulator blocks adipocyte differentiation but stimulates glucose uptake in 3T3-L1 adipocytes.
Mukherjee R; Hoener PA; Jow L; Bilakovics J; Klausing K; Mais DE; Faulkner A; Croston GE; Paterniti JR
Mol Endocrinol; 2000 Sep; 14(9):1425-33. PubMed ID: 10976920
[TBL] [Abstract][Full Text] [Related]
3. T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.
Lee G; Elwood F; McNally J; Weiszmann J; Lindstrom M; Amaral K; Nakamura M; Miao S; Cao P; Learned RM; Chen JL; Li Y
J Biol Chem; 2002 May; 277(22):19649-57. PubMed ID: 11877444
[TBL] [Abstract][Full Text] [Related]
4. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB
Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571
[TBL] [Abstract][Full Text] [Related]
5. Adipocyte differentiation is regulated by a prostaglandin liganded to the nuclear peroxisome proliferator-activated receptor.
Wolf G
Nutr Rev; 1996 Sep; 54(9):290-2. PubMed ID: 9009672
[TBL] [Abstract][Full Text] [Related]
6. Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation.
Albrektsen T; Frederiksen KS; Holmes WE; Boel E; Taylor K; Fleckner J
Diabetes; 2002 Apr; 51(4):1042-51. PubMed ID: 11916924
[TBL] [Abstract][Full Text] [Related]
7. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis.
Gurnell M; Wentworth JM; Agostini M; Adams M; Collingwood TN; Provenzano C; Browne PO; Rajanayagam O; Burris TP; Schwabe JW; Lazar MA; Chatterjee VK
J Biol Chem; 2000 Feb; 275(8):5754-9. PubMed ID: 10681562
[TBL] [Abstract][Full Text] [Related]
8. Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
Berger J; Leibowitz MD; Doebber TW; Elbrecht A; Zhang B; Zhou G; Biswas C; Cullinan CA; Hayes NS; Li Y; Tanen M; Ventre J; Wu MS; Berger GD; Mosley R; Marquis R; Santini C; Sahoo SP; Tolman RL; Smith RG; Moller DE
J Biol Chem; 1999 Mar; 274(10):6718-25. PubMed ID: 10037770
[TBL] [Abstract][Full Text] [Related]
9. A novel potent antagonist of peroxisome proliferator-activated receptor gamma blocks adipocyte differentiation but does not revert the phenotype of terminally differentiated adipocytes.
Camp HS; Chaudhry A; Leff T
Endocrinology; 2001 Jul; 142(7):3207-13. PubMed ID: 11416043
[TBL] [Abstract][Full Text] [Related]
10. A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.
Wright HM; Clish CB; Mikami T; Hauser S; Yanagi K; Hiramatsu R; Serhan CN; Spiegelman BM
J Biol Chem; 2000 Jan; 275(3):1873-7. PubMed ID: 10636887
[TBL] [Abstract][Full Text] [Related]
11. Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro.
Su JL; Winegar DA; Wisely GB; Sigel CS; Hull-Ryde EA
Hybridoma; 1999 Jun; 18(3):273-80. PubMed ID: 10475242
[TBL] [Abstract][Full Text] [Related]
12. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma.
Forman BM; Tontonoz P; Chen J; Brun RP; Spiegelman BM; Evans RM
Cell; 1995 Dec; 83(5):803-12. PubMed ID: 8521497
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect.
Armoni M; Kritz N; Harel C; Bar-Yoseph F; Chen H; Quon MJ; Karnieli E
J Biol Chem; 2003 Aug; 278(33):30614-23. PubMed ID: 12777391
[TBL] [Abstract][Full Text] [Related]
14. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
[TBL] [Abstract][Full Text] [Related]
15. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
Lehmann JM; Moore LB; Smith-Oliver TA; Wilkison WO; Willson TM; Kliewer SA
J Biol Chem; 1995 Jun; 270(22):12953-6. PubMed ID: 7768881
[TBL] [Abstract][Full Text] [Related]
16. PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic.
Misra P; Chakrabarti R; Vikramadithyan RK; Bolusu G; Juluri S; Hiriyan J; Gershome C; Rajjak A; Kashireddy P; Yu S; Surapureddi S; Qi C; Zhu YJ; Rao MS; Reddy JK; Ramanujam R
J Pharmacol Exp Ther; 2003 Aug; 306(2):763-71. PubMed ID: 12730351
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity.
Oberkofler H; Esterbauer H; Linnemayr V; Strosberg AD; Krempler F; Patsch W
J Biol Chem; 2002 May; 277(19):16750-7. PubMed ID: 11875072
[TBL] [Abstract][Full Text] [Related]
18. T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.
Li Y; Wang Z; Furukawa N; Escaron P; Weiszmann J; Lee G; Lindstrom M; Liu J; Liu X; Xu H; Plotnikova O; Prasad V; Walker N; Learned RM; Chen JL
J Biol Chem; 2008 Apr; 283(14):9168-76. PubMed ID: 18263587
[TBL] [Abstract][Full Text] [Related]
19. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.
Davies SS; Pontsler AV; Marathe GK; Harrison KA; Murphy RC; Hinshaw JC; Prestwich GD; Hilaire AS; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 2001 May; 276(19):16015-23. PubMed ID: 11279149
[TBL] [Abstract][Full Text] [Related]
20. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties.
Reginato MJ; Bailey ST; Krakow SL; Minami C; Ishii S; Tanaka H; Lazar MA
J Biol Chem; 1998 Dec; 273(49):32679-84. PubMed ID: 9830009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
